JOURNAL ARTICLE
RESEARCH SUPPORT, NON-U.S. GOV'T
Add like
Add dislike
Add to saved papers

Recurrence of spider naevi following treatment with 585 nm pulsed dye laser.

During a 2-year period 201 patients underwent treatment for spider naevi with a 585nm pulsed dye laser at Canniesburn Hospital Laser Suite. Patients were treated with a either single or double pulse technique. Of these patients 191 (95%) had a successful result, with clearance in a mean of 1.8 treatments (range, 1-7). There was no significant difference between the two treatment protocols in terms of probability of clearing the lesion or number of treatments required. These 191 patients were contacted by postal survey to determine their long-term results. The mean duration of follow-up was 37.9 months (range, 27-51 months). Response rate to the survey was 73%, 139 patients. Fifty patients (36%) had suffered recurrence of their spider naevi in the same site. There was no correlation found between the risk of recurrence and the site, number of treatments received, size and characteristics of the spider naevus, or treatment protocol used. The risk of recurrence increased with increasing age and was higher for peripheral facial lesions. The most common time of recurrence was between 6 and 18 months with 48% of recurrences occurring during this period. Existing published series, which have demonstrated low recurrence rates, have either had low numbers of patients or short follow-up periods of less than 6 months.

Full text links

For the best experience, use the Read mobile app

Group 7SearchHeart failure treatmentPapersTopicsCollectionsEffects of Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Patients With Heart Failure Importance: Only 1 class of glucose-lowering agents-sodium-glucose cotransporter 2 (SGLT2) inhibitors-has been reported to decrease the risk of cardiovascular events primarily by reducingSeptember 1, 2017: JAMA CardiologyAssociations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment study.CONCLUSIONS: Increased UACR is common in patients with heart failure, including non-diabetics. Urinary albumin creatininineJul, 2011: European Journal of Heart FailureRandomized Controlled TrialEffects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.Review

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app